Group One Trading
CAPR icon

Group One Trading’s Capricor Therapeutics CAPR Stock Holding History

Group One Trading’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.68M Buy
176,900
+75,000
+74% +$831K ﹤0.01% 2299
2026
Q2 		$2.45M Sell
101,900
-26,000
-20% -$788K ﹤0.01% 2033
2026
Q1 		$3.89M Sell
127,900
-339,900
-73% -$9.06M 0.01% 1498
2025
Q4 		$13.5M Buy
467,800
+276,900
+145% +$3.62M 0.02% 765
2025
Q3 		$1.38M Sell
190,900
-50,100
-21% -$369K ﹤0.01% 2691
2025
Q2 		$2.39M Buy
241,000
+124,700
+107% +$1.32M 0.01% 1958
2025
Q1 		$1.1M Buy
116,300
+7,800
+7% +$108K ﹤0.01% 2376
2024
Q4 		$1.5M Buy
108,500
+48,800
+82% +$855K ﹤0.01% 2173
2024
Q3 		$908K Buy
59,700
+51,300
+611% +$254K ﹤0.01% 2383
2024
Q2 		$40.1K Buy
8,400
+7,300
+664% +$40.7K ﹤0.01% 4687
2024
Q1 		$7.47K Sell
1,100
-2,900
-73% -$14K ﹤0.01% 6014
2023
Q4 		$19.6K Buy
4,000
+800
+25% +$2.6K ﹤0.01% 5764
2023
Q3 		$10.9K Sell
3,200
-5,800
-64% -$32.6K ﹤0.01% 6288
2023
Q2 		$43K Sell
9,000
-5,700
-39% -$25K ﹤0.01% 5395
2023
Q1 		$62K Sell
14,700
-7,800
-35% -$33.6K ﹤0.01% 4693
2022
Q4 		$86.8K Sell
22,500
-6,000
-21% -$28.6K ﹤0.01% 4553
2022
Q3 		$171K Buy
28,500
+2,400
+9% +$12.3K ﹤0.01% 4289
2022
Q2 		$91K Buy
26,100
+13,700
+110% +$48.6K ﹤0.01% 5064
2022
Q1 		$43K Sell
12,400
-3,700
-23% -$14.6K ﹤0.01% 6200
2021
Q4 		$47K Sell
16,100
-19,400
-55% -$68K ﹤0.01% 6383
2021
Q3 		$143K Sell
35,500
-57,700
-62% -$263K ﹤0.01% 5523
2021
Q2 		$478K Buy
93,200
+55,000
+144% +$233K ﹤0.01% 4264
2021
Q1 		$179K Buy
38,200
+37,100
+3,373% +$214K ﹤0.01% 5135
2020
Q4 		$4K Sell
1,100
-5,500
-83% -$23.8K ﹤0.01% 6081
2020
Q3 		$35K Buy
6,600
+6,300
+2,100% +$36.7K ﹤0.01% 4852
2020
Q2 		$1K Buy
+300
New +$1.31K ﹤0.01% 5627

Other funds holding CAPR

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
DG Capital Management
DG Capital Management New York $451M AUM 20.71% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
HBK Sorce Advisory
HBK Sorce Advisory Erie, Pennsylvania $5.18B AUM 12.38% 1-Year Est. Return

Group One Trading's CAPR Position: Q3 2026 in Review

Group One Trading reduced its Capricor Therapeutics (CAPR) stake by 51% in Q3 2026, selling an estimated $1.54M and leaving 133,714 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2557.

Group One Trading first reported a position in CAPR in Q1 2021 and has held it in 19 quarters since. The position peaked at $6.56M in Q2 2026. 77 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.

  • Group One Trading held 133,714 shares of Capricor Therapeutics worth $1.27M as of Q3 2026.
  • Group One Trading sold 138,895 Capricor Therapeutics shares in Q3 2026, an estimated $1.54M.
  • Capricor Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #2557 holding.
  • Group One Trading first reported a position in Capricor Therapeutics in Q1 2021 and has held it in 19 quarters since.
  • Group One Trading's Capricor Therapeutics position peaked at $6.56M in Q2 2026.
  • 77 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.